STOCK TITAN

bluebird bio to Present at Leerink Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

bluebird bio (NASDAQ: BLUE) will participate in the 10th Annual SVB Leerink Global Healthcare Conference on February 25 at 12:00 p.m. ET. A live webcast of the event can be accessed on the company’s website, with a replay available for 90 days post-event. bluebird bio specializes in developing gene therapies for severe genetic diseases and cancer, aiming to provide treatments for conditions with limited options. The company operates from multiple locations including Cambridge, Seattle, Durham, and Zug.

Positive
  • None.
Negative
  • None.

bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will participate in the 10th Annual SVB Leerink Global Healthcare Conference, Thursday, February 25, at 12:00 p.m. ET.

To access the live webcast of bluebird bio’s presentation, please visit the “Events & Presentations” page within the Investors & Media section of the bluebird bio website at http://investor.bluebirdbio.com. A replay of the webcast will be available on the bluebird bio website for 90 days following the event.

About bluebird bio, Inc.

bluebird bio is pioneering gene therapy with purpose. From our Cambridge, Mass., headquarters, we’re developing gene therapies for severe genetic diseases and cancer, with the goal that people facing potentially fatal conditions with limited treatment options can live their lives fully. Beyond our labs, we’re working to positively disrupt the healthcare system to create access, transparency and education so that gene therapy can become available to all those who can benefit.

bluebird bio is a human company powered by human stories. We’re putting our care and expertise to work across a spectrum of disorders including cerebral adrenoleukodystrophy, sickle cell disease, β-thalassemia and multiple myeloma, using three gene therapy technologies: gene addition, cell therapy and (megaTAL-enabled) gene editing.

bluebird bio has additional nests in Seattle, Wash.; Durham, N.C.; and Zug, Switzerland. For more information, visit bluebirdbio.com.

Follow bluebird bio on social media: @bluebirdbio, LinkedIn, Instagram and YouTube.

bluebird bio is a trademark of bluebird bio, Inc.

FAQ

When is bluebird bio's presentation at the SVB Leerink Global Healthcare Conference?

bluebird bio's presentation is on February 25 at 12:00 p.m. ET.

How can I access the bluebird bio presentation webcast?

The live webcast can be accessed on the Events & Presentations page of bluebird bio's website.

How long will the bluebird bio presentation replay be available?

The playback of the presentation will be available for 90 days following the event.

What is bluebird bio's focus in gene therapy?

bluebird bio focuses on gene therapies for severe genetic diseases and cancer.

Where are bluebird bio's headquarters located?

The headquarters of bluebird bio is in Cambridge, Massachusetts.

bluebird bio, Inc.

NASDAQ:BLUE

BLUE Rankings

BLUE Latest News

BLUE Stock Data

80.75M
193.91M
0.63%
43.76%
25.48%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
SOMERVILLE